FindTrial
Sign In

Feasibility of inspiratory muscle training to improve pulmonary and respiratory muscle function, and for attenuating sleep apnea symptoms in children and adolescent with obstructive sleep apnea and obesity: Case report

Feasibility of inspiratory muscle training to improve pulmonary and respiratory muscle function, and for attenuating sleep apnea symptoms in children and adolescent with obstructive sleep apnea and obesity: Case report

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210611007
Enrollment
5
Registered
2021-06-11
Start date
2021-06-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary function and respiratory muscle function in children and adolescents with obstructive sleep apnea and obesity inspiratory muscle training, obstructive sleep apnea, obesity, children and adolescents, case report

Interventions

Inspiratory muscle training (IMT) was performed using the POWERbreathe Classic light device. Protocol for the IMT group consisted of 12 weeks of home-based training with moderate resistance (60% of MI
Active Comparator Device
inspiratory muscle training (IMT) with resistance 60% of MIP

Sponsors

Faculty of Associated Medical Sciences, Chiang Mai University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1. Children and adolescents at snoring clinic 2. Obstructive sleep apnea diagnosed by polysomnography (AHI > 1 events/hour) and doctor 3. Individuals classified as obese based on International Obesity Task Force (IOTF) criteria

Exclusion criteria

Exclusion criteria: 1. Abnormal chest shape (e.g., funnel chest, pigeon chest) 2. Craniofacial syndrome 3. Have underlying disease effect on pulmonary function , respiratory muscle function and inspiratory muscle training (e.g., sinusitis, respiratory tract infection, spinal cord injury, rib fracture, pneumonia, spontaneous/traumatic pneumothorax, ruptured eardrum/condition of the ear) 4. Receive pharmacological treatment that effect to decrease respiratory muscle function

Design outcomes

Primary

MeasureTime frame
pulmonary function variables before, after 3 week, after 6 week, after 9 week and after 12 week of the intervention pulmonary function test,inspiratory muscle strength before, after 3 week, after 6 week, after 9 week and after 12 week of the intervention maximal inspiratory pressure (MIP),respiratory muscle endurance before, after 3 week, after 6 week, after 9 week and after 12 week of the intervention maximal voluntary ventilation (MVV)—

Secondary

MeasureTime frame
Sleep Related Breathing Disorder-Pediatric Sleep Questionnaire (SRBD-PSQ) scores before, after 3 week, after 6 week, after 9 week and after 12 week of the intervention Sleep Related Breathing Disorder-Pediatric Sleep Questionnaire (SRBD-PSQ) scores—

Countries

Thailand

Contacts

Public ContactSainatee Pratanaphon

Department of Physical Therapy, Faculty of Associated Medical Sciences, Chiang Mai University

sainatee.pra@cmu.ac.th0897001599

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026